The total return over the past 12 months is +417.35% vs. +16.94% for the S&P 500. So far it's up -3.79% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +417.35% | +125.39% | (0.21%) | N/A | N/A | N/A |
| Total Return CAGR | +417.35% | +125.39% | (0.21%) | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Praxis Precision Medicines, Inc. (PRAX)
| Year | Start price | End price | PRAX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $294.74 | $283.56 | (3.79%) | +14.51% | (18.30%) |
| 2025 | $76.96 | $294.74 | +282.98% | +17.72% | +265.26% |
| 2024 | $22.28 | $76.96 | +245.42% | +24.89% | +220.53% |
| 2023 | $35.70 | $22.28 | (37.59%) | +26.19% | (63.78%) |
| 2022 | $295.50 | $35.70 | (87.92%) | (18.17%) | (69.75%) |
| 2021 | $825.30 | $295.50 | (64.19%) | +28.74% | (92.93%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
